Lonez相关文献与解析，生知库 | 链接生命科学的每一步

Clinical Proof-of-Concept of a Non-Gene Editing Technology Using miRNA-Based shRNA to Engineer Allogeneic CAR T-Cells

利用基于 miRNA 的 shRNA 对同种异体 CAR T 细胞进行改造的非基因编辑技术的临床概念验证

期刊:International Journal of Molecular Sciences

Lonez, Caroline; Bolsée, Jennifer; Huberty, Fanny; Nguyen, Thuy; Jacques-Hespel, Céline; Anguille, Sebastien; Flament, Anne; Breman, Eytan

Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?

同种异体CAR-T疗法技术：是否已实现预期目标？

期刊:Cells

影响因子:5.2

doi:10.3390/cells13020146

Lonez, Caroline; Breman, Eytan

发表日期：2024

文献求助收藏

Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform

利用嵌合miRNA簇平台高效敲低多个靶基因用于细胞治疗

期刊:Molecular Therapy-Nucleic Acids

影响因子:6.5

doi:10.1016/j.omtn.2023.102038

Matteo Rossi ，Mikhail Steklov ，Fanny Huberty ，Thuy Nguyen ，Jérôme Marijsse ，Céline Jacques-Hespel ，Paul Najm ，Caroline Lonez ，Eytan Breman

miRNA

发表日期：2023

文献求助收藏

Important Food Sources of Fructose-Containing Sugars and Postprandial Lipids: A Systematic Review and Meta-Analysis of Controlled Feeding Trials

含果糖类和餐后脂质的重要食物来源：一项控制喂养试验的系统评价和荟萃分析

期刊:Cellular and Molecular Life Sciences

影响因子:6.2

doi:10.1007/s00018-007-7520-1

Lonez, C; Legat, A; Vandenbranden, M; Ruysschaert, J-M; Au-Yeung, Fei; Chiavaroli, Laura; Khan, Tauseef; Zurbau, Andreea; Ayoub-Charette, Sabrina; Cheung, Annette; Ahmed, Amna; Lee, Danielle; Liu, Qi; Choo, Vivian; Mejia, Sonia Blanco; de Souza, Russell; Wolever, Thomas; Leiter, Lawrence; Kendall, Cyril; Jenkins, David; Sievenpiper, John

发表日期：2021

文献求助收藏

Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies

嵌合抗原受体T细胞靶向实体瘤：当前挑战和现有策略

期刊:BioDrugs

影响因子:6.9

doi:10.1007/s40259-019-00368-z

Springuel, Lorraine; Lonez, Caroline; Alexandre, Bertrand; Van Cutsem, Eric; Machiels, Jean-Pascal H; Van Den Eynde, Marc; Prenen, Hans; Hendlisz, Alain; Shaza, Leila; Carrasco, Javier; Canon, Jean-Luc; Opyrchal, Mateusz; Odunsi, Kunle; Rottey, Sylvie; Gilham, David E; Flament, Anne; Lehmann, Frédéric F

Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4

酰基链饱和将心磷脂从拮抗剂转化为 Toll 样受体 4 的激活剂

期刊:Cellular and Molecular Life Sciences

影响因子:6.2

doi:10.1007/s00018-019-03113-5

Malvina Pizzuto, Caroline Lonez, Alberto Baroja-Mazo, Helios Martínez-Banaclocha, Panagiotis Tourlomousis, Monique Gangloff, Pablo Pelegrin, Jean-Marie Ruysschaert, Nicholas J Gay, Clare E Bryant

Correction to: Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4

更正：酰基链的饱和作用使心磷脂从 Toll 样受体 4 的拮抗剂转变为激活剂。

期刊:Cellular and Molecular Life Sciences

影响因子:6.2

doi:10.1007/s00018-019-03229-8

Pizzuto, Malvina; Lonez, Caroline; Baroja-Mazo, Alberto; Martínez-Banaclocha, Helios; Tourlomousis, Panagiotis; Gangloff, Monique; Pelegrin, Pablo; Ruysschaert, Jean-Marie; Gay, Nicholas J; Bryant, Clare E

信号转导

发表日期：2019

文献求助收藏

NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient

基于NKG2D的嵌合抗原受体疗法使一名复发/难治性急性髓系白血病患者病情缓解。

期刊:Haematologica

影响因子:7.9

doi:10.3324/haematol.2017.186742

Sallman, David A; Brayer, Jason; Sagatys, Elizabeth M; Lonez, Caroline; Breman, Eytan; Agaugué, Sophie; Verma, Bikash; Gilham, David E; Lehmann, Frédéric F; Davila, Marco L

Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers

Toll 样受体 2 的混杂性决定了核酸纳米载体的免疫刺激活性

期刊:Journal of Controlled Release

影响因子:10.5

doi:10.1016/j.jconrel.2016.12.029

Malvina Pizzuto, Monique Gangloff, Daniel Scherman, Nicholas J Gay, Virginie Escriou, Jean-Marie Ruysschaert, Caroline Lonez

Tandem CAR T-cells targeting CD19 and NKG2DL can overcome CD19 antigen escape in B-ALL

靶向 CD19 和 NKG2DL 的串联 CAR T 细胞可以克服 B 细胞急性淋巴细胞白血病 (B-ALL) 中的 CD19 抗原逃逸。

Clinical Proof-of-Concept of a Non-Gene Editing Technology Using miRNA-Based shRNA to Engineer Allogeneic CAR T-Cells

利用基于 miRNA 的 shRNA 对同种异体 CAR T 细胞进行改造的非基因编辑技术的临床概念验证

Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?

同种异体CAR-T疗法技术：是否已实现预期目标？

Efficient shRNA-based knockdown of multiple target genes for cell therapy using a chimeric miRNA cluster platform

利用嵌合miRNA簇平台高效敲低多个靶基因用于细胞治疗

Important Food Sources of Fructose-Containing Sugars and Postprandial Lipids: A Systematic Review and Meta-Analysis of Controlled Feeding Trials

含果糖类和餐后脂质的重要食物来源：一项控制喂养试验的系统评价和荟萃分析

Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies

嵌合抗原受体T细胞靶向实体瘤：当前挑战和现有策略

Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4

酰基链饱和将心磷脂从拮抗剂转化为 Toll 样受体 4 的激活剂

Correction to: Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4

更正：酰基链的饱和作用使心磷脂从 Toll 样受体 4 的拮抗剂转变为激活剂。

NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient

基于NKG2D的嵌合抗原受体疗法使一名复发/难治性急性髓系白血病患者病情缓解。

Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers

Toll 样受体 2 的混杂性决定了核酸纳米载体的免疫刺激活性